logo
logo

Cryogenx raises £1.7M seed round to tackle heat stress. The funding will drive FDA clearance and scale up manufacturing and sales.

Jul 15, 202518 days ago

Amount Raised

£1.7 Million

Round Type

seed

LondonMedical DeviceHealth CareManufacturing

Investors

Uki2 S

Description

Cryogenx’s CGX1 offers rapid treatment for heat-related illness without the need for refrigeration. They aim to transform heat injury prevention across military and civilian sectors. The funding will support FDA clearance and expanded international sales. This innovation addresses a critical global challenge in operational safety.

Company Information

Company

Cryogenx

Location

London, England, United Kingdom

About

Cryogenx is a London-based healthtech startup that offers a portable body cooling device for heat-related illness. Their patent-pending technology features a powerful coolant stored within compact cylinders that is injected into an adhesive, thermally conductive pad placed on the patient’s torso, providing immediate and on-demand solution for heat-related illnesses.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers